Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2013 08:30 ET | Source: Novavax, Inc.

Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC

ROCKVILLE, Md., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage biopharmaceutical company creating novel vaccines based on recombinant nanoparticle technology, today...
August 08, 2013 08:00 ET | Source: Novavax, Inc.

Novavax Reports Second-Quarter 2013 Financial Results

ROCKVILLE, Md., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company creating novel recombinant nanoparticle vaccines to address a broad range of...
August 06, 2013 16:30 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 2013 Wedbush Life Sciences Conference

ROCKVILLE, Md., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
August 01, 2013 08:30 ET | Source: Novavax, Inc.

Novavax to Report Second Quarter 2013 Financial Results on August 8, 2013

ROCKVILLE, Md., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call and live webcast to report its second quarter 2013 financial results...
July 29, 2013 07:52 ET | Source: Novavax, Inc.

Novavax Publishes Positive Preclinical Efficacy Data Against Influenza A(H7N9)

Positive efficacy data from its A(H7N9) vaccine published in the peer-reviewed scientific journal Vaccine Novavax vaccine-induced immunity provided 100% protection against lethal wild-type...
July 08, 2013 07:30 ET | Source: Novavax, Inc.

Novavax Initiates First Phase 1 Clinical Trial of Its A(H7N9) Influenza Vaccine Candidate

ROCKVILLE, Md., July 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 1 clinical trial of its monovalent virus-like particle (VLP) vaccine...
July 02, 2013 07:30 ET | Source: Novavax, Inc.

Novavax Announces Positive Top-Line Results From Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly

Well-tolerated without any vaccine-related serious adverse events Adjuvant enhanced response seen in all dose levels Anti-F IgG antibodies to the F protein in serum rose 3.0-5.7 fold...
June 24, 2013 16:19 ET | Source: Novavax, Inc.

Novavax Appoints Barclay "Buck" Phillips as Senior Vice President and Chief Financial Officer

ROCKVILLE, Md., June 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the appointment of Barclay A. "Buck" Phillips to the position of Senior Vice President and Chief Financial...
June 06, 2013 07:00 ET | Source: Novavax, Inc.

Novavax Produces MERS-CoV Vaccine Candidate

ROCKVILLE, Md., June 6, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it had successfully produced a vaccine candidate designed to provide protection against the recently...
June 04, 2013 07:00 ET | Source: Novavax, Inc.

Novavax Announces Public Offer for All Outstanding Shares of Isconova

Adds proprietary nanoparticle matrix immune-modulating adjuvant technology to Novavax's recombinant vaccine development platform Total transaction valued at approximately $29.6 million...